More on PHAT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+74.7% Growth)
- Ratings (9.2 Score)
- FDA

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Phathom Pharmaceuticals Inc. (NQ:PHAT)
Delayed: 10.88 -0.12 (1.09%)
Prev. Close $11.00  
Open$11.24 
52 Wk High$ 
52 Wk Low$ 
Day High$11.40 
Day Low$10.59 
P/E N/A  
EPS$ 
Volume1,121,786 

Friends, Peers and Foes (?): CDTX, HLVX, IPO SAGE (more...)

Jun 17, 2026 06:50 AM H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
May 27, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 22 Filed by: Parikh Asit
May 22, 2026 08:00 AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
May 21, 2026 05:16 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: Parikh Asit
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: FIELDS HEIDI
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: Stenhouse Mark
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: Topper James N
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: KARBE FRANK
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: Schroeder Theodore R
May 21, 2026 04:30 PM Form 4 Phathom Pharmaceuticals, For: May 19 Filed by: COLA MICHAEL F
View All Articles

Entities mentioned with PHAT

View All Entities